Thousands of diabetes patients could be spared a limb amputation thanks to ground-breaking AI technology that has helped Barts Life Sciences identify people at risk from complications. Clinicians at Barts Health NHS Trust, one of the largest trusts in the UK, say it would have taken a clinician over 100 years to review the volume of data analysed in a...
Clinithink artificial intelligence software takes just weeks to sift through data that would take a human more than a century – enabling quicker treatment that could save limbs. The Clinithink software analysed 14.2 million medical records and notes to identify patients with diabetic foot disease. A new AI technology being trialled at a major NHS hosptial trust could transform treatment...
Barts Life Sciences and SEHTA are delighted to announce that Professor Sir Mark Caulfield, CEO of Barts Life Sciences will be the keynote speaker at the SEHTA 2021 International MedTech Expo & Conference. About the conference: Friday 8th October 2021, Hilton London Tower Bridge Hotel www.sehtamedtechexpo.co.uk The SME focused healthcare event driving collaborations between business, care, clinicians & academics Improving...
By Sophie Williams, Digital Pioneer Fellow Patient input is vital to medical research. Scientists need to hear about patient experiences to be sure that they are researching the most pressing questions. In a clinical trial the potential benefit of a new drug needs to be clearly explained to convince an individual to join the trial. But in data research the...
A team led by researchers from Queen Mary University of London has developed a new artificial intelligence (AI) tool that is able to automatically measure the amount of fat around the heart from MRI scan images. Using the new tool, the team was able to show that a larger amount of fat around the heart is associated with significantly greater...
A clinical trial testing a new Oxford / AstraZeneca vaccine against Covid-19 has opened to recruitment at Barts Health NHS Trust. Volunteers are needed to take part in the study (a phase II/III clinical trial), which is led by the University of Oxford and AstraZeneca and supported by the National Institute of Health Research. The trial aims to test the...
Professor Sir Mark Caulfield has been announced as the new Chief Executive Officer of Barts Life Sciences. Barts Life Sciences, a research and innovation partnership between Barts Health NHS Trust and Queen Mary University of London, is driving the development of a world-leading life sciences campus at Whitechapel focusing on digital health, genomics and clinical innovation. The programme aims to develop...
***PRESS RELEASE*** We are delighted to welcome the 49 interns participating in our 2021 Black Internship Programme. As the UK’s national institute for health data science and the alliance of UK health data custodians, Health Data Research UK (HDR UK) and UK Health Data Research Alliance (the Alliance) hope to help transform the prospects of and provide the opportunities for, young Black people in the UK, allowing them to flourish in their future science,...
COVID-19 has accelerated data-driven innovation across the globe, with AI and data science at the forefront of addressing human disease and health. Read London & Partners and MedCity’s new report on London’s strengths as a hub for health & life sciences: https://adobe.ly/3cvSfOC
Barts Health is one of the largest NHS trusts in the country, and one of Britain’s leading healthcare providers. The Barts Health group of NHS hospitals is entering an exciting new era on our improvement journey to becoming an outstanding organisation with a world-class clinical reputation. Having lifted ourselves out of special measures, we now have the impetus and breathing...
Accessibility options
Translate the page